Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.

Abstract:

:Congenital afibrinogenemia is a rare inherited coagulopathy, characterized by very low or unmeasurable plasma levels of immunoreactive fibrinogen. So far, 25 mutations have been identified in afibrinogenemia, 17 in the Aalpha, 6 in the gamma, and only 2 in the Bbeta fibrinogen-chain genes. Here, 2 afibrinogenemic probands, showing undetectable levels of functional fibrinogen, were screened for causative mutations at the genomic level. Sequence analysis of the 3 fibrinogen genes disclosed 2 novel homozygous mutations in introns 6 and 7 of the Bbeta-chain gene (IVS6 + 13C > T and IVS7 + 1G > T), representing the first Bbeta-chain gene splicing mutations described in afibrinogenemia. The IVS6 + 13C > T mutation predicts the creation of a donor splice site in intron 6, whereas the IVS7 + 1G > T mutation causes the disappearance of the invariant GT dinucleotide of intron 7 donor splice site. To analyze the effect of these mutations, expression plasmids containing Bbeta-chain minigene constructs, either wild-type or mutant, were transfected in HeLa cells. Assessed by semiquantitative analysis of reverse transcriptase-polymerase chain reaction products, the IVS7 + 1G > T mutation resulted in multiple aberrant splicings, while the IVS6 + 13C > T mutation resulted in activation of a new splice site 11 nucleotides downstream of the physiologic one. Both mutations are predicted to determine protein truncations, supporting the importance of the C-terminal domain of the Bbeta chain for fibrinogen assembly and secretion.

journal_name

Blood

journal_title

Blood

authors

Spena S,Duga S,Asselta R,Malcovati M,Peyvandi F,Tenchini ML

doi

10.1182/blood-2002-06-1647

subject

Has Abstract

pub_date

2002-12-15 00:00:00

pages

4478-84

issue

13

eissn

0006-4971

issn

1528-0020

pii

2002-06-1647

journal_volume

100

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Unraveling hemophilic arthropathy.

    abstract::In this issue of Blood, Acharya and colleagues provide evidence for the role of angiogenesis in the pathophysiology of hemophilic joint disease. Is this the linchpin that unravels this important clinical condition or merely a cog in a not so stepwise process? ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2011-01-327312

    authors: Abshire T

    更新日期:2011-02-24 00:00:00

  • Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.

    abstract::The improved outcome of acquired aplastic anemia (AA) has revealed later complications, such as myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML). We retrospectively analyzed 167 children with severe acquired AA. Eleven of 50 children treated with cyclosporin (CSA) and recombinant human granulocyte c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ohara A,Kojima S,Hamajima N,Tsuchida M,Imashuku S,Ohta S,Sasaki H,Okamura J,Sugita K,Kigasawa H,Kiriyama Y,Akatsuka J,Tsukimoto I

    更新日期:1997-08-01 00:00:00

  • Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins.

    abstract::Mast cells are inflammatory and immunoregulatory cells resident in tissues. They develop from bone marrow-derived progenitor cells that enter the tissue through the blood circulation. The specific localization and migration of mast cells in tissues is dependent on their interaction with extracellular matrix (ECM) prot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.3.966

    authors: Lorentz A,Schuppan D,Gebert A,Manns MP,Bischoff SC

    更新日期:2002-02-01 00:00:00

  • Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF).

    abstract::In this cooperative study, we explored the role of the carbohydrate moiety (CHO) of von Willebrand factor (vWF) in supporting platelet adhesion. Because of previous discrepant results, all purification steps and CHO modifications by various enzymes were critically evaluated. Under our conditions, CHO-modified vWF prep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Federici AB,De Romeuf C,De Groot PG,Samor B,Lombardi R,D'Alessio P,Mazurier C,Mannucci PM,Sixma JJ

    更新日期:1988-04-01 00:00:00

  • Cytosolic free calcium changes induced by chemotactic peptide in neutrophils from patients with chronic granulomatous disease.

    abstract::Cytoplasmic free calcium concentration (Ca2+)i was measured in neutrophils from patients with the classical X-linked form of chronic granulomatous disease (CGD) by trapping the fluorescent calcium indicator Quin 2 in intact cells. CGD neutrophils do not produce superoxide and are only slightly depolarized upon stimula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lew PD,Wollheim C,Seger RA,Pozzan T

    更新日期:1984-01-01 00:00:00

  • Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6.

    abstract::Hepcidin is the master regulator of iron homeostasis. In the liver, iron-dependent hepcidin activation is regulated through Bmp6 and its membrane receptor hemojuvelin (Hjv), whereas, in response to iron deficiency, hepcidin repression seems to be controlled by a pathway involving the serine protease matriptase-2 (enco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-295147

    authors: Lenoir A,Deschemin JC,Kautz L,Ramsay AJ,Roth MP,Lopez-Otin C,Vaulont S,Nicolas G

    更新日期:2011-01-13 00:00:00

  • In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs.

    abstract::Interleukin-6 (IL-6) administered as a single intravenous (IV) injection caused the following changes in the peripheral circulation of rats: (a) a biphasic neutrophilia with an initial peak at 1.5 hours and a second sustained wave of neutrophilia between four and 12 hours, (b) a mild lymphocytosis at 0.5 hours and a m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ulich TR,del Castillo J,Guo KZ

    更新日期:1989-01-01 00:00:00

  • Update on clinical gene therapy for hemophilia.

    abstract::In contrast to other diverse therapies for the X-linked bleeding disorder hemophilia that are currently in clinical development, gene therapy holds the promise of a lasting cure with a single drug administration. Near-to-complete correction of hemophilia A (factor VIII deficiency) and hemophilia B (factor IX deficienc...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-07-820720

    authors: Perrin GQ,Herzog RW,Markusic DM

    更新日期:2019-01-31 00:00:00

  • Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.

    abstract::As B-cell chronic lymphocytic leukemia (B-CLL) progresses, malignant cells extravasate and infiltrate lymphoid tissues. Several molecules, including gelatinase B/MMP-9, contribute to these processes. Although mainly a secreted protease, some MMP-9 is present at the B-CLL cell surface and the function, mode of anchorin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-109249

    authors: Redondo-Muñoz J,Ugarte-Berzal E,García-Marco JA,del Cerro MH,Van den Steen PE,Opdenakker G,Terol MJ,García-Pardo A

    更新日期:2008-07-01 00:00:00

  • A mutation in the Gardos channel is associated with hereditary xerocytosis.

    abstract::The Gardos channel is a Ca(2+)-sensitive, intermediate conductance, potassium selective channel expressed in several tissues including erythrocytes and pancreas. In normal erythrocytes, it is involved in cell volume modification. Here, we report the identification of a dominantly inherited mutation in the Gardos chann...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-04-642496

    authors: Rapetti-Mauss R,Lacoste C,Picard V,Guitton C,Lombard E,Loosveld M,Nivaggioni V,Dasilva N,Salgado D,Desvignes JP,Béroud C,Viout P,Bernard M,Soriani O,Vinti H,Lacroze V,Feneant-Thibault M,Thuret I,Guizouarn H,Badens C

    更新日期:2015-09-10 00:00:00

  • Involvement of bcl-2 gene in Japanese follicular lymphoma.

    abstract::A t(14;18) (q32;q21) chromosome translocation is closely associated with the follicular lymphoma, which is prevalent in the United States, and the t(14;18) causes the juxtaposition of a bcl-2 gene on chromosome 18 with an immunoglobulin heavy-chain gene locus on chromosome 14. Genomic DNAs from 30 Japanese patients wi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Amakawa R,Fukuhara S,Ohno H,Doi S,Oguma S,Tanabe S,Yamabe H,Edamura S,Tomono N,Nasu K

    更新日期:1989-02-15 00:00:00

  • Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

    abstract::In haploidentical transplantation, the mismatched haplotype of the donor can originate from either of the parents. We refer to such mismatched haplotypes as noninherited maternal antigens (NIMA haplotype) or noninherited paternal antigens (NIPA haplotype). To determine whether exposure to maternal HLA antigens benefit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.5.1572

    authors: van Rood JJ,Loberiza FR Jr,Zhang MJ,Oudshoorn M,Claas F,Cairo MS,Champlin RE,Gale RP,Ringdén O,Hows JM,Horowitz MH

    更新日期:2002-03-01 00:00:00

  • Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs.

    abstract::Whereas the final differentiation of conventional dendritic cells (CDCs) from committed precursors occurs locally in secondary lymphoid or peripheral tissues, plasmacytoid dendritic cells (PDCs) are thought to fully develop in the bone marrow from common DC progenitors before migrating to the periphery. In our study, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-326678

    authors: Schlitzer A,Loschko J,Mair K,Vogelmann R,Henkel L,Einwächter H,Schiemann M,Niess JH,Reindl W,Krug A

    更新日期:2011-06-16 00:00:00

  • A special report: bone marrow transplants using volunteer donors--recommendations and requirements for a standardized practice throughout the world--1994 update. The WMDA Executive Committee.

    abstract::A primary function of the World Marrow Donor Association is to establish general guidelines covering collaboration between international donor registries and practice in regard to bone marrow transplants (BMTs) in which the donor and recipient reside in different countries. To this end, a special report proposing spec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Goldman JM

    更新日期:1994-11-01 00:00:00

  • Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines.

    abstract::Erythropoietin (EPO) is the hormone necessary for development of erythrocytes from immature erythroid cells. EPO activates Jun N-terminal kinase (JNK), a member of the mitogen-activated protein kinase (MAPK) family in the EPO-dependent murine erythroid HCD57 cells. Therefore, we tested if JNK activity supported prolif...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1754

    authors: Jacobs-Helber SM,Sawyer ST

    更新日期:2004-08-01 00:00:00

  • PGE2-induced metalloproteinase-9 is essential for dendritic cell migration.

    abstract::Following antigen acquisition and maturation, dendritic cells (DCs) disengage from the extracellular matrix, cross basement membranes, and travel to draining lymph nodes to activate T cells. CCR7 expression is necessary but not sufficient for the directional migration of DCs. Prostaglandin E2 (PGE2), present in inflam...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-05-090613

    authors: Yen JH,Khayrullina T,Ganea D

    更新日期:2008-01-01 00:00:00

  • Regulation of early human hematopoietic (BFU-E and CFU-GEMM) progenitor cells in vitro by interleukin 1-induced fibroblast-conditioned medium.

    abstract::Stimulators of human erythroid burst-forming units (BFU-E) and multipotential colony-forming cells (CFU-GEMM) can be produced by a number of different cell types. A product of human peripheral blood monocytes, interleukin 1 (IL-1), was evaluated for its ability to stimulate fibroblast cultures to produce stimulators o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zucali JR,Broxmeyer HE,Dinarello CA,Gross MA,Weiner RS

    更新日期:1987-01-01 00:00:00

  • Activation of human platelets by the rabbit anticardiolipin antibodies.

    abstract::Affinity purified anticardiolipin antibodies (ACLA) raised in rabbits showed cross-reactivities with various negatively charged phospholipids as shown by both the solid phase enzyme-linked immunosorbent assay (ELISA) and inhibition studies. In ELISA, ACLA showed strong cross-reactivity to both sphingomyelin (SM) and p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lin YL,Wang CT

    更新日期:1992-12-15 00:00:00

  • The beta-adrenergic receptor adenylate cyclase complex of Rauscher murine erythroleukemia cells and its response to erythropoietin-induced differentiation.

    abstract::Rauscher murine erythroleukemia cells, grown continuously in vitro, undergo erythroid differentiation in response to the hormone erythropoietin. Therefore, they serve as an important model system with which to examine critical biochemical aspects of this developmental process. Intact, uninduced Rauscher cells possess ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sytkowski AJ,Kessler CJ

    更新日期:1984-07-01 00:00:00

  • How I treat gastrointestinal bleeding in congenital and acquired von Willebrand disease.

    abstract::Gastrointestinal (GI) bleeding is distinctive of severe von Willebrand disease (VWD), generally arising in older patients; in most cases, blood transfusion and hospitalization are required. The presence of arteriovenous malformations is often described when endoscopic examinations are performed. Patients with congenit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003702

    authors: Biguzzi E,Siboni SM,Peyvandi F

    更新日期:2020-09-03 00:00:00

  • Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation.

    abstract::Activated protein C (APC) is inhibited by two major plasma inhibitors (PCIs). To find evidence for in vivo complexation of APC, immunoblotting studies were performed on plasmas of 85 patients with suspected disseminated intravascular coagulation (DIC). Samples from 62 of these patients contained 5% to 35% of protein C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Heeb MJ,Mosher D,Griffin JH

    更新日期:1989-02-01 00:00:00

  • Characterization of the mouse von Willebrand factor promoter.

    abstract::Expression of the von Willebrand factor (vWF) gene is restricted to the endothelial and megakaryocyte lineages. Within the endothelium, expression of vWF varies between different vascular beds. We have previously shown that the human vWF promoter spanning a region between -2182 (relative to the start site of transcrip...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guan J,Guillot PV,Aird WC

    更新日期:1999-11-15 00:00:00

  • FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma.

    abstract::Adult T-cell leukemia/lymphoma (ATLL) is an incurable disease where most patients succumb within the first year of diagnosis. Both standard chemotherapy regimens and mAbs directed against ATLL tumor markers do not alter this aggressive clinical course. Therapeutic development would be facilitated by the discovery of g...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-319467

    authors: Elliott NE,Cleveland SM,Grann V,Janik J,Waldmann TA,Davé UP

    更新日期:2011-10-06 00:00:00

  • Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions.

    abstract::The effectiveness of arabinosylcytosine (ara-C) for the treatment of acute myelogenous leukemia (AML) depends on the formation of its active metabolite, the triphosphate of ara-C (ara-CTP). Using biochemical modulation strategies to increase the accumulation of ara-CTP in leukemia blasts, a clinical protocol was desig...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Gandhi V,Estey E,Keating MJ,Chucrallah A,Plunkett W

    更新日期:1996-01-01 00:00:00

  • Identification of human lymphoma cells by antisera to malignancy-associated nucleolar antigens.

    abstract::The non-Hodgkin's lymphomas (NHL) are a diverse group of human lymphoid neoplasms that have long presented pathologists with formidable diagnostic challenges. These tumors of the immune system are thought to represent neoplastic transformations of most of the recognized stages in T and B lymphocyte ontogeny. Lymphoma ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ford RJ,Cramer M,Davis FM

    更新日期:1984-03-01 00:00:00

  • Gain of von Willebrand factor-binding function by mutagenesis of a species-conserved residue within the leucine-rich repeat region of platelet glycoprotein Ibalpha.

    abstract::Glycoprotein (GP) Ibalpha, a member of the leucine-rich repeat (LRR) protein family, mediates platelet adhesion to immobilized von Willebrand factor (VWF). We investigated the role in VWF binding of charged residues in the LRR region of GP Ibalpha that are conserved in human, canine, and murine proteins. Substitution ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0514

    authors: Peng Y,Shrimpton CN,Dong JF,López JA

    更新日期:2005-09-15 00:00:00

  • Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.

    abstract::Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translocation and a high number of secondary chromosomal alterations. However, only a limited number of target genes have been identified. We have studied 10 MCL cell lines and 28 primary tumors with a combination of a high-density single...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-170183

    authors: Beà S,Salaverria I,Armengol L,Pinyol M,Fernández V,Hartmann EM,Jares P,Amador V,Hernández L,Navarro A,Ott G,Rosenwald A,Estivill X,Campo E

    更新日期:2009-03-26 00:00:00

  • Detection of factor VIII inhibitors with the partial thromboplastin time.

    abstract::Variations of the partial thromboplastin time (PTT) were tested to determine the best screening method for detection of inhibitors of factor VIII. Variables tested included the duration of preincubation of a mixture of patient plasma and factor VIII source (normal plasma), the ratio of the patient plasma to the normal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lossing TS,Kasper CK,Feinstein DI

    更新日期:1977-05-01 00:00:00

  • Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas.

    abstract::Primary cutaneous lymphomas have been successfully treated with interferons (IFNs), counterbalancing the T-helper 2 (Th2)-skewing state. We undertook a phase 1, open-label, dose-escalating trial of repeated intratumoral administration of TG1042 in patients with advanced primary cutaneous T-cell lymphomas (CTCLs) and m...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-01-0360

    authors: Dummer R,Hassel JC,Fellenberg F,Eichmüller S,Maier T,Slos P,Acres B,Bleuzen P,Bataille V,Squiban P,Burg G,Urosevic M

    更新日期:2004-09-15 00:00:00

  • Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.

    abstract::Patients with relapsed chronic lymphocytic leukemia (CLL) and high-risk features, such as fludarabine refractoriness, complex karyotype, or abnormalities of chromosome 17p, experience poor outcomes after standard fludaradine-based regimens. Alemtuzumab is a chimeric CD52 monoclonal antibody with activity in CLL patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-341032

    authors: Badoux XC,Keating MJ,Wang X,O'Brien SM,Ferrajoli A,Faderl S,Burger J,Koller C,Lerner S,Kantarjian H,Wierda WG

    更新日期:2011-08-25 00:00:00